Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
Clicks: 358
ID: 5916
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
77.4
/100
358 views
292 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #130 of 1,693 articles by views in Infection and drug resistance
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,693 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (29 words).
Try re-searching for a better abstract.
| Reference Key |
chihcheng2019susceptibilityinfection
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Chih-Cheng Lai;Ying-Sheng Chen;Nan-Yao Lee;Hung-Jen Tang;Susan Shin-Jung Lee;Chin-Fu Lin;Po-Liang Lu;Jiunn-Jong Wu;Wen-Chien Ko;Wen-Sen Lee;Po-Ren Hsueh and |
| Journal | Infection and drug resistance |
| Year | 2019 |
| DOI |
10.2147/IDR.S194482
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.